[go: up one dir, main page]

PL199633A1 - Sposob wytwarzania 5-m-toliloksyuracylu - Google Patents

Sposob wytwarzania 5-m-toliloksyuracylu

Info

Publication number
PL199633A1
PL199633A1 PL19963377A PL19963377A PL199633A1 PL 199633 A1 PL199633 A1 PL 199633A1 PL 19963377 A PL19963377 A PL 19963377A PL 19963377 A PL19963377 A PL 19963377A PL 199633 A1 PL199633 A1 PL 199633A1
Authority
PL
Poland
Prior art keywords
tolyloxyuracyl
making
Prior art date
Application number
PL19963377A
Other languages
English (en)
Other versions
PL103783B1 (pl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL199633A1 publication Critical patent/PL199633A1/pl
Publication of PL103783B1 publication Critical patent/PL103783B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PL1977199633A 1976-07-16 1977-07-14 Sposob wytwarzania 5-m-toliloksyuracylu PL103783B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (2)

Publication Number Publication Date
PL199633A1 true PL199633A1 (pl) 1978-04-10
PL103783B1 PL103783B1 (pl) 1979-07-31

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977199633A PL103783B1 (pl) 1976-07-16 1977-07-14 Sposob wytwarzania 5-m-toliloksyuracylu

Country Status (29)

Country Link
US (1) US4080454A (pl)
JP (1) JPS5337673A (pl)
AR (1) AR213652A1 (pl)
AT (1) AT351561B (pl)
BE (1) BE856710A (pl)
CA (1) CA1061788A (pl)
CH (1) CH622512A5 (pl)
CS (1) CS212264B2 (pl)
DD (1) DD131556A5 (pl)
DE (1) DE2731736A1 (pl)
DK (1) DK139029B (pl)
EG (1) EG12762A (pl)
ES (1) ES460686A1 (pl)
FI (1) FI772183A7 (pl)
FR (1) FR2358399A1 (pl)
GB (1) GB1542178A (pl)
GR (1) GR68686B (pl)
HU (1) HU177713B (pl)
IL (1) IL52409A (pl)
LU (1) LU77764A1 (pl)
NL (1) NL7707729A (pl)
NO (1) NO772489L (pl)
PH (1) PH13190A (pl)
PL (1) PL103783B1 (pl)
PT (1) PT66808B (pl)
SE (1) SE421125B (pl)
SU (1) SU673169A3 (pl)
YU (1) YU171677A (pl)
ZA (1) ZA773927B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
NZ565955A (en) 2005-08-22 2011-08-26 Melior Pharmaceuticals I Inc Methods and formulations for modulating lyn kinase activity and treating related disorders
CN101686686A (zh) * 2007-02-20 2010-03-31 梅里奥尔医药I公司 鉴别Lyn激酶激活剂的方法
CA2693809A1 (en) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
KR102634575B1 (ko) 2017-04-10 2024-02-06 멜리어 파마슈티칼스 아이, 인코포레이티드 지방세포의 처리
US20210106581A1 (en) 2018-02-21 2021-04-15 Melior Pharmaceuticals I, Inc. Treatment Of Liver Diseases

Also Published As

Publication number Publication date
NL7707729A (nl) 1978-01-18
AU2663877A (en) 1978-05-18
YU171677A (en) 1982-06-30
DK139029B (da) 1978-12-04
FR2358399A1 (fr) 1978-02-10
DD131556A5 (de) 1978-07-05
PL103783B1 (pl) 1979-07-31
GR68686B (pl) 1982-02-01
FI772183A7 (pl) 1978-01-17
PT66808B (en) 1978-12-21
CH622512A5 (pl) 1981-04-15
IL52409A (en) 1979-11-30
DK139029C (pl) 1979-05-07
SU673169A3 (ru) 1979-07-05
GB1542178A (en) 1979-03-14
FR2358399B1 (pl) 1980-10-17
DE2731736A1 (de) 1978-01-26
ES460686A1 (es) 1978-12-01
IL52409A0 (en) 1977-08-31
HU177713B (en) 1981-12-28
US4080454A (en) 1978-03-21
LU77764A1 (pl) 1978-02-02
BE856710A (fr) 1978-01-11
CA1061788A (en) 1979-09-04
DK318177A (pl) 1978-01-17
JPS5512017B2 (pl) 1980-03-29
NO772489L (no) 1978-01-17
EG12762A (en) 1979-12-31
ZA773927B (en) 1978-05-30
PT66808A (en) 1977-08-01
SE421125B (sv) 1981-11-30
CS212264B2 (en) 1982-03-26
PH13190A (en) 1980-01-16
SE7707471L (sv) 1978-01-17
JPS5337673A (en) 1978-04-06
ATA509277A (de) 1979-01-15
AR213652A1 (es) 1979-02-28
AT351561B (de) 1979-08-10

Similar Documents

Publication Publication Date Title
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL195088A1 (pl) Sposob wytwarzania n-fosfonometyloglicyny
PL200289A1 (pl) Sposob wytwarzania zwiazkow 3-chlorocefemowych
PL199798A1 (pl) Sposob wytwarzania gamma-pironow
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL199298A1 (pl) Sposob wytwarzania 2-bromo-6-fluoro-n-2-imidazolidynylideno-benzaminy
PL196820A1 (pl) Sposob wytwarzania zwiazkow 3-chlorowcometylocefemowych-3
PL199942A1 (pl) Sposob wytwarzania nowych pierscieniowych szesciopeptydow
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL202091A1 (pl) Sposob wytwarzania gamma-pyronow
PL199633A1 (pl) Sposob wytwarzania 5-m-toliloksyuracylu
PL201885A1 (pl) Sposob wytwarzania 4a-arylo-osmiowodoro-1h-2-piryndyn
PL104866B1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL195267A1 (pl) Sposob wytwarzania(2-ketopirolidyno)-alkanokarbonamidow
PL200570A1 (pl) Sposob wytwarzania nowych aryloalkiloamin
PL202697A1 (pl) Sposob wytwarzania 2-bromo-alfa-ergokryptyny
PL197646A1 (pl) Sposob wytwarzania pochodnych 1-karbamylouracylu
PL199670A1 (pl) Sposob wytwarzania dwuaminoalkoksybenzenow
PL202935A1 (pl) Sposob wytwarzania estrow
PL190443A1 (pl) Sposob otrzymywania p-nitrodwufenyloaminy
IT1081020B (it) Metodo di fabbricazione di aspidospermidine
PL96646B1 (pl) Sposob wytwarzania alkilo-beta-dl-rybopiranozydow
PL192043A1 (pl) Sposob wytwarzania polinitrozwiazkow